Effects of angiotensin II receptor blockade on N-terminal proatrial natriuretic factor plasma levels in chronic heart failure

Journal of Cardiac Failure

Volumn 3, Issue 2, 1997, Pages 75-81

  Klinge, Randi ^a   Polis, Adam ^c   Dickstein, Kenneth ^b   Hall, Christian ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b STAVANGER UNIVERSITY HOSPITAL   (Norway)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Angiotensin II receptor antagonism; Atrial natriuretic factor; Chronic heart failure

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ATRIAL NATRIURETIC FACTOR; BIPHENYL DERIVATIVE; IMIDAZOLE DERIVATIVE; LOSARTAN; PROTEIN PRECURSOR; TETRAZOLE DERIVATIVE;

AGED; ARTICLE; BLOOD; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; FEMALE; HEMODYNAMICS; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL;

AGED; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; BIPHENYL COMPOUNDS; DOUBLE-BLIND METHOD; FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; IMIDAZOLES; LOSARTAN; MALE; MIDDLE AGED; PROTEIN PRECURSORS; RECEPTORS, ANGIOTENSIN; TETRAZOLES;

EID: 0031154848     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(97)90038-5     Document Type: Article

References (24)

1. Itoh H, Nakao K, Sugawara A, Saito Y, Mukoyama M, Morii N, Yamada T, Shiono S, Arai H, Hosoda K, Imura H: Gamma-atrial natriuretic polypeptide (gammaANP)-derived peptides in human plasma: cosecretion of N-terminal gammaANP fragment and alfaANP. J Clin Endocrinol Metab 1988;67:429-37
2. Sundsfjord JA, Thibault G, Larochelle P, Cantin M: Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man. J Clin Endocrinol Metab 1988;66:605-10
3. Nelesen RA, Dimsdale JE, Ziegler MG: Plasma atrial natriuretic peptide is unstable under most storage conditions. Circulation 1992;86:463-6
4. Hall C, Aaberge L, Stokke O: In vitro stability of N-terminal proatrial natriuretic factor in unfrozen samples: an important prerequisite for its use as a biochemical parameter of atrial pressure in clinical routine. Circulation 1995; 91:911
5. Edwards BS, Zimmerman RS, Schwab TR, Heublein DM, Burnett JC Jr: Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ Res 1988;62(2):191-5
6. Dietz JR, Nazian SJ, Vesely DL: Release of ANF, proANF 1-98, and proANF 31-67 from isolated rat atria by atrial distension. Am J Physiol 1991;260:H1774
7. Matsubara H, Nishikawa M, Umeda Y, Taniguchi T, Iwasaka T, Kurimoto T, Yamane Y, Inada, M: The role of atrial pressure in secreting atrial natriuretic polypeptides. Am Heart J 1987;113:1457-63
8. Nakamura M, Kawata Y, Yoshida H, Arakawa N, Koeda T, Ichikawa T, Funakoshi T, Hiramori K: Relationship between plasma atrial and brain natriuretic peptide concentration and hemodynamic parameters during percutaneous transvenous mitral valvulotomy in patients with mitral stenosis. Am Heart J 1992;124:1283-8
9. Mathisen P, Hall C, Simonsen S: Comparative study of atrial peptides ANF(1-98) and ANF(99-126) as diagnostic markers of atrial distension in patients with cardiac disease. Scand J Clin Lab Invest 1993;53:41-9
10. Lerman A, Gibbons RJ, Rodeheffer RJ, Bailey KR, McKinley LJ, Heublein DM, Burnett JC Jr: Circulating N-terminal atrial natriuretic peptidc as a marker for symptomless left-ventricular dysfunction. Lancet 1993;341:1105-9
11. Hall C, Kjekshus J, Eneroth P, Snapinn, S: The plasma concentration of N-terminal proatrial natriuretic factor ANF(1-98) is related to prognosis in severe heart failure. Clin Cardiol 1994;17(4):191-5
12. Dickstein K, Larsen AI, Bonarjee V, Thoresen M, Aarsland T, Hall C: Plasma proatrial natriuretic factor is predictive of clinical status in patients with congestive heart failure. Am J Cardiol 1995;76:679-83
13. Hall C, Rouleau JL, Moy L, Champlain J, Bichet D, Klein M, Sussex B, Packer M, Rouleau J, Arnold MO, Lamas GA, Sestier F, Gottlieb SS, Wun CC, Pfeffer MA: N-terminal proatrial natriuretic factor: an independent predictor of long-term prognosis after myocardial infarction. Circulation 1994;89:1934-42
14. Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL, Timmermans PBMWM: Nonpeptide angiotensin II receptor antagonists: VIII. Characterization of functional antagonism displayed by DuP753, an orally active antihypertensive agent. J Pharmacol Exp Ther 1990;252:719-25
15. Gottlieb SS, Dickstein K, Fleck E, Kostis J, Levine TB, LeJemtel T, DeKock M: Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure. Circulation 1993;88: 1602-9
16. Dickstein K, Chang P, Willenheimer R, Haunso S, Remes J, Hall C, Kjekshus J: Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure. J Am Coll Cardiol 1995;26:438-45
17. Crozier I, Ikram H, Awan N, Cleland J, Stephen N, Dickstein K, Frey M, Young J, Klinger G, Makris L, Rucinska E: Losartan in heart failure: hemodynamic effects and tolerability. Circulation 1995;91:691-7
18. Feinstem AR, Fisher MB, Pigeon JG: Changes in dyspnea-fatigue ratings as indicators of quality of life in the treatment of convestive heart failure. Am J Cardiol 1989; 64:50-5
19. Hochberg Y: A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988;75:800-2
20. Volpe M, Atlas SA, Sosa RE, Marion DE, Mueller FB, Sealy JE, Lragh JH: Angiotensin II-induced atrial natriuretic factor release in dogs is not related to hemodynamic responses. Circ Res 1990;67:774-9
21. Sato F, Kamoi K, Wakiya Y, Ozawa T, Arai O, Ishibashi M, Yamaji T: Relationship between plasma atrial natriuretic peptide levels and atrial pressure in man. J Clin Endocrinol Metab 1986;63:823-7
22. Richards AM, Cleland JGF, Tonolo G, McIntyre GD, Leckie BJ, Dargie HJ, Ball SG, Robertson JIS: Plasma α natriuretic peptide in cardiac impairment. Br Med J 1986; 293:409-12
23. Katsube N, Schwartz D, Needleman P: Atriopeptin turnover: quantitative relationship between in vivo changes in plasma levels and atrial content. J Pharmacol Exp Ther 1986;239:474-9
24. Moe GW, Rouleau JL, Proulx G, Arnold M, Sestier F: Increased mortality with flosequinan in patients with failure is accompanied by increased plasma norepinephrine. Circulation 1994;90(4,pt 2) (abstr).